Hospital
Carroll Hospital Center, INC.
Carroll Hospital Center, INC. was paid $1.41M by Medicaid between Jan 2018 and Nov 2024, across 63 billing codes. Its largest line is G0378, Hospital observation service, per hour — 39% of everything it billed.
33Billing provider infoCARROLL HOSPITAL CENTER, INC.
WESTMINSTER, MD 21157
WESTMINSTER, MD 21157
33aNPI1912904210assigned 06/30/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.41M
24GClaims59,993
24DCodes billed63
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Maryland
Rank by total paid#28 of 69
Median peer was paid$870K
This provider vs. median1.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,677 | $2K | |
| 2019 | 9,795 | $155K | |
| 2020 | 7,230 | $250K | |
| 2021 | 9,572 | $337K | |
| 2022 | 8,276 | $277K | |
| 2023 | 7,797 | $287K | |
| 2024incomplete | 4,646 | $105K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0378 | Hospital observation service, per hour | 39% | 1,209 | 1,082 | $553K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 26% | 4,033 | 3,558 | $363K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 24% | 2,887 | 2,576 | $335K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 8.0% | 2,058 | 1,858 | $112K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2.3% | 1,094 | 681 | $32K |
| 80053 | Comprehensive metabolic panel | <1% | 7,642 | 5,940 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,452 | 2,204 | $2K |
| 84484 | <1% | 3,804 | 2,899 | $2K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,028 | 5,685 | $1K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,932 | 3,381 | $1K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 580 | 561 | $1K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,845 | 1,691 | $916.28 |
51 more codes
| 84702 | <1% | 1,094 | $871.26 | |
| 81001 | <1% | 3,710 | $857.32 | |
| 83690 | <1% | 1,419 | $451.73 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 161 | $422.34 |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,861 | $331.09 |
| 85027 | <1% | 1,267 | $265.68 | |
| 85610 | <1% | 192 | $226.91 | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 327 | $219.58 |
| 83735 | <1% | 2,244 | $178.62 | |
| 83605 | <1% | 318 | $174.43 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 247 | $136.92 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,004 | $113.91 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 960 | $96.23 |
| 87088 | <1% | 505 | $69.64 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 255 | $57.61 |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 27 | $53.81 |
| 87040 | <1% | 26 | $52.25 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 216 | $51.33 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,937 | $48.50 |
| 86850 | <1% | 16 | $32.67 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 290 | $25.43 |
| 94760 | <1% | 509 | $22.10 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 200 | $17.36 |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 232 | $14.90 |
| 86901 | <1% | 16 | $10.89 | |
| 86900 | <1% | 16 | $10.89 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 618 | $8.85 |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 164 | $1.05 |
| J2704 | Injection, propofol, 10 mg | 0% | 33 | $0.00 |
| 83880 | 0% | 354 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 0% | 20 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 54 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 12 | $0.00 |
| 80320 | 0% | 69 | $0.00 | |
| 71045 | Radiologic examination, chest; single view | 0% | 310 | $0.00 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 0% | 42 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 36 | $0.00 |
| 87077 | 0% | 12 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 62 | $0.00 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 74 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 46 | $0.00 |
| 85379 | 0% | 12 | $0.00 | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 0% | 19 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 13 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 33 | $0.00 |
| 94799 | 0% | 159 | $0.00 | |
| 87186 | 0% | 24 | $0.00 | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 0% | 73 | $0.00 |
| 85007 | 0% | 15 | $0.00 | |
| 94664 | 0% | 113 | $0.00 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMYERS, MICHAEL (VICE PRESIDENT OF FINANCE)
| Provider | Location | Paid |
|---|---|---|
| Bridginglife, INC. | Westminster, MD | $22.07M |
| Universal Healthcare Mso, LLC | Bakersfield, CA | $2.67M |
| Carroll Health Group, LLC | Westminster, MD | $2.38M |
| Carroll Health Group, LLC | Westminster, MD | $110K |
| Carroll Regional Cancer Center Physicians, LLC | Westminster, MD | $82K |
| Carroll Hospital Center, INC. | Westminster, MD | $923.43 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.